project id: TCGA-STAD; case submitter id: TCGA-IN-A6RS; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.71; rna integrity number: 8.3; age at index: 76; days to birth: -27808; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1937; age at diagnosis: 27808; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 383.0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 127; initial weight: 220.0; sample id: b5c52eea-05ec-4c00-9487-363ad14e4d26; sample submitter id: TCGA-IN-A6RS-01A; portion id: 105d542b-ccbd-4bef-b925-5fbda09ba283; portion submitter id: TCGA-IN-A6RS-01A-12; slide id: a6d69bb1-4140-44ae-8fa7-8142a1f907d2; slide submitter id: TCGA-IN-A6RS-01A-01-TSA; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 2.0; percent necrosis: 10.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0; section location: TOP;